Herbalife Ltd $HLF Shares Sold by Manatuck Hill Partners LLC

Manatuck Hill Partners LLC lowered its position in shares of Herbalife Ltd (NYSE:HLF) by 12.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 875,000 shares of the company’s stock after selling 125,000 shares during the period. Herbalife accounts for approximately 3.9% of Manatuck Hill Partners LLC’s portfolio, making the stock its 3rd largest position. Manatuck Hill Partners LLC owned 0.85% of Herbalife worth $11,279,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of HLF. GSA Capital Partners LLP purchased a new stake in Herbalife in the third quarter valued at $911,000. CenterBook Partners LP purchased a new stake in Herbalife in the third quarter valued at $368,000. Picton Mahoney Asset Management purchased a new stake in Herbalife in the third quarter valued at $898,000. Invenomic Capital Management LP purchased a new stake in Herbalife in the third quarter valued at $3,550,000. Finally, Diversify Wealth Management LLC lifted its position in Herbalife by 25.4% in the third quarter. Diversify Wealth Management LLC now owns 345,385 shares of the company’s stock valued at $2,787,000 after acquiring an additional 70,061 shares during the last quarter.

Insider Buying and Selling

In other Herbalife news, COO Troy Hicks sold 38,377 shares of the stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $12.93, for a total transaction of $496,214.61. Following the transaction, the chief operating officer owned 9,062 shares of the company’s stock, valued at $117,171.66. This trade represents a 80.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Frank Lamberti sold 134,982 shares of the firm’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $13.50, for a total transaction of $1,822,257.00. Following the completion of the transaction, the insider directly owned 36,624 shares in the company, valued at approximately $494,424. This represents a 78.66% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 191,296 shares of company stock worth $2,551,678. 5.13% of the stock is currently owned by insiders.

Herbalife Price Performance

HLF stock opened at $11.65 on Thursday. The company’s 50 day simple moving average is $13.86 and its 200-day simple moving average is $14.87. The firm has a market capitalization of $1.21 billion, a PE ratio of 5.11, a P/E/G ratio of 0.70 and a beta of 0.88. Herbalife Ltd has a 12 month low of $7.56 and a 12 month high of $20.40.

Herbalife (NYSE:HLF) last announced its earnings results on Wednesday, May 6th. The company reported $0.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.61 by $0.03. Herbalife had a net margin of 4.67% and a negative return on equity of 41.47%. The firm had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.30 billion. During the same quarter last year, the business earned $0.59 earnings per share. Herbalife’s revenue was up 7.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that Herbalife Ltd will post 2.47 earnings per share for the current year.

Analyst Upgrades and Downgrades

HLF has been the subject of a number of research reports. Mizuho set a $17.00 target price on shares of Herbalife in a report on Monday, May 4th. Weiss Ratings raised shares of Herbalife from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday. Wall Street Zen raised shares of Herbalife from a “buy” rating to a “strong-buy” rating in a report on Saturday, April 18th. Royal Bank Of Canada dropped their price target on shares of Herbalife from $17.00 to $16.00 and set a “sector perform” rating on the stock in a research note on Tuesday, April 28th. Finally, Zacks Research lowered shares of Herbalife from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 20th. Three investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $17.80.

Herbalife Profile

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.